CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma ; volume:21 ; number:1 ; day:13 ; month:10 ; year:2020 ; pages:1-9 ; date:12.2020
Respiratory research ; 21, Heft 1 (13.10.2020), 1-9, 12.2020
- Creator
-
Emson, Claire
Diver, Sarah
Chachi, Latifa
Megally, Ayman
Small, Cherrie
Downie, John
Parnes, Jane R.
Bowen, Karin
Colice, Gene
Brightling, Chris E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-020-01513-x
- URN
-
urn:nbn:de:101:1-2020112819103805778758
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Emson, Claire
- Diver, Sarah
- Chachi, Latifa
- Megally, Ayman
- Small, Cherrie
- Downie, John
- Parnes, Jane R.
- Bowen, Karin
- Colice, Gene
- Brightling, Chris E.
- SpringerLink (Online service)
Other Objects (12)
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
The great uncontrolled
The great uncontrolled
Coffee break has no impact on laparoscopic skills: a randomized double-blinded placebo-controlled parallel-group trial
Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study
Airway fibrin formation cascade in allergic asthma exacerbation: implications for inflammation and remodeling
Uncontrolled headache induced by oxcarbazepine
The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial
Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
The great uncontrolled
The great uncontrolled
Coffee break has no impact on laparoscopic skills: a randomized double-blinded placebo-controlled parallel-group trial
Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study
Airway fibrin formation cascade in allergic asthma exacerbation: implications for inflammation and remodeling
Uncontrolled headache induced by oxcarbazepine
The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial
Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
The great uncontrolled
The great uncontrolled
Coffee break has no impact on laparoscopic skills: a randomized double-blinded placebo-controlled parallel-group trial
Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study
Airway fibrin formation cascade in allergic asthma exacerbation: implications for inflammation and remodeling
Uncontrolled headache induced by oxcarbazepine
The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial